Literature DB >> 370902

Radiobiological considerations in the use of total-body irradiation for bone-marrow transplantation.

L J Peters, H R Withers, J H Cundiff, K A Dicke.   

Abstract

On radiobiological grounds, a therapeutic advantage should result when total body irradiation (TBI) in preparation for bone-marrow engraftment is given as a fractionated course, rather than as a single exposure at logistically reasonable dose rates. This is because cells of hemopoietic origin in general show less capacity for repair of sublethal radiation injury than do cells of other organs. Dose-limiting lung tolerance, in the context of fractionated TBI, is estimated to be at least 12 Gy (without correction) in increments of 2 Gy regardless of dose rate. A practical method for delivering TBI using a high-energy linear accelerator is described.

Entities:  

Mesh:

Year:  1979        PMID: 370902     DOI: 10.1148/131.1.243

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  15 in total

1.  Blood and marrow transplantation: a perspective from the University of Minnesota.

Authors:  John H Kersey
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 2.  Bone marrow transplantation. Part II--autologous.

Authors:  N J Chao; K G Blume
Journal:  West J Med       Date:  1990-01

3.  The accuracy of dose determination during total body irradiation.

Authors:  J Malicki
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

4.  Bone marrow transplantation in Canada.

Authors:  N A Buskard
Journal:  Can Med Assoc J       Date:  1980-07-05       Impact factor: 8.262

5.  Current practice in total-body irradiation: results of a Canada-wide survey.

Authors:  R C N Studinski; D J Fraser; R S Samant; M S MacPherson
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

6.  Total body irradiation (TBI) in pediatric patients. A single-center experience after 30 years of low-dose rate irradiation.

Authors:  Claudia Linsenmeier; Daniel Thoennessen; Laura Negretti; Jean-Pierre Bourquin; Tino Streller; Urs Martin Lütolf; Susanne Oertel
Journal:  Strahlenther Onkol       Date:  2010-11-08       Impact factor: 3.621

7.  Barriers to the successful treatment of liver disease by hepatocyte transplantation.

Authors:  Kyle A Soltys; Alejandro Soto-Gutiérrez; Masaki Nagaya; Kevin M Baskin; Melvin Deutsch; Ryotaro Ito; Benjamin L Shneider; Robert Squires; Jerry Vockley; Chandan Guha; Jayanta Roy-Chowdhury; Stephen C Strom; Jeffrey L Platt; Ira J Fox
Journal:  J Hepatol       Date:  2010-06-30       Impact factor: 25.083

8.  Lack of recovery from radiation-induced sublethal damage in human haematopoietic cells.

Authors:  B F Kimler; C H Park; D Yakar; R M Mies
Journal:  Br J Cancer Suppl       Date:  1984

Review 9.  Conditioning regimens for hematopoietic cell transplantation: one size does not fit all.

Authors:  Boglarka Gyurkocza; Brenda M Sandmaier
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

10.  Similar effects on murine haemopoietic compartment of low dose rate single dose and high dose rate fractionated total body irradiation. Preliminary results after a unique dose of 750 cGy.

Authors:  T Girinski; G Socie; J M Cosset; J Dutreix; D Chassagne
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.